These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30061386)

  • 41. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
    Mori T; Boyd MR
    Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission.
    Ramessar K; Rademacher T; Sack M; Stadlmann J; Platis D; Stiegler G; Labrou N; Altmann F; Ma J; Stöger E; Capell T; Christou P
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3727-32. PubMed ID: 18316741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving the large scale purification of the HIV microbicide, griffithsin.
    Fuqua JL; Wanga V; Palmer KE
    BMC Biotechnol; 2015 Feb; 15(1):12. PubMed ID: 25887919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transgenic Production of an Anti HIV Antibody in the Barley Endosperm.
    Hensel G; Floss DM; Arcalis E; Sack M; Melnik S; Altmann F; Rutten T; Kumlehn J; Stoger E; Conrad U
    PLoS One; 2015; 10(10):e0140476. PubMed ID: 26461955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transgenic rice endosperm as a bioreactor for molecular pharming.
    Ou J; Guo Z; Shi J; Wang X; Liu J; Shi B; Guo F; Zhang C; Yang D
    Plant Cell Rep; 2014 Apr; 33(4):585-94. PubMed ID: 24413763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetics of β-carotene degradation under different storage conditions in transgenic Golden Rice® lines.
    Bollinedi H; Dhakane-Lad J; Gopala Krishnan S; Bhowmick PK; Prabhu KV; Singh NK; Singh AK
    Food Chem; 2019 Apr; 278():773-779. PubMed ID: 30583442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms.
    Niemer M; Mehofer U; Torres Acosta JA; Verdianz M; Henkel T; Loos A; Strasser R; Maresch D; Rademacher T; Steinkellner H; Mach L
    Biotechnol J; 2014 Apr; 9(4):493-500. PubMed ID: 24478053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional characterization of the recombinant HIV-neutralizing monoclonal antibody 2F5 produced in maize seeds.
    Sabalza M; Madeira L; van Dolleweerd C; Ma JK; Capell T; Christou P
    Plant Mol Biol; 2012 Nov; 80(4-5):477-88. PubMed ID: 22965278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study.
    Marusic C; Vitale A; Pedrazzini E; Donini M; Frigerio L; Bock R; Dix PJ; McCabe MS; Bellucci M; Benvenuto E
    Transgenic Res; 2009 Aug; 18(4):499-512. PubMed ID: 19169897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing.
    Alam A; Jiang L; Kittleson GA; Steadman KD; Nandi S; Fuqua JL; Palmer KE; Tusé D; McDonald KA
    Front Bioeng Biotechnol; 2018; 6():102. PubMed ID: 30087892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plant made anti-HIV microbicides--a field of opportunity.
    Lotter-Stark HC; Rybicki EP; Chikwamba RK
    Biotechnol Adv; 2012; 30(6):1614-26. PubMed ID: 22750509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Riboflavin fortification of rice endosperm by metabolic engineering.
    Tian YS; Xu J; Wang B; Fu XY; Gao JJ; Han HJ; Li ZJ; Wang LJ; Zhang FJ; Zhang WH; Deng YD; Wang Y; Peng RH; Yao QH
    Plant Biotechnol J; 2021 Aug; 19(8):1483-1485. PubMed ID: 33977612
    [No Abstract]   [Full Text] [Related]  

  • 53. An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.
    Lotfi H; Sheervalilou R; Zarghami N
    Bioimpacts; 2018; 8(2):139-151. PubMed ID: 29977835
    [No Abstract]   [Full Text] [Related]  

  • 54. Chemically Programmed Antibodies AS HIV-1 Attachment Inhibitors.
    Sato S; Inokuma T; Otsubo N; Burton DR; Barbas CF
    ACS Med Chem Lett; 2013 May; 4(5):460-465. PubMed ID: 23750312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bulk production of the antiviral lectin griffithsin.
    Fuqua JL; Hamorsky K; Khalsa G; Matoba N; Palmer KE
    Plant Biotechnol J; 2015 Oct; 13(8):1160-8. PubMed ID: 26176205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.
    Duan H; Chen X; Boyington JC; Cheng C; Zhang Y; Jafari AJ; Stephens T; Tsybovsky Y; Kalyuzhniy O; Zhao P; Menis S; Nason MC; Normandin E; Mukhamedova M; DeKosky BJ; Wells L; Schief WR; Tian M; Alt FW; Kwong PD; Mascola JR
    Immunity; 2018 Aug; 49(2):301-311.e5. PubMed ID: 30076101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies.
    Rathore U; Purwar M; Vignesh VS; Das R; Kumar AA; Bhattacharyya S; Arendt H; DeStefano J; Wilson A; Parks C; La Branche CC; Montefiori DC; Varadarajan R
    J Biol Chem; 2018 Sep; 293(39):15002-15020. PubMed ID: 30093409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DEER Spectroscopy Measurements Reveal Multiple Conformations of HIV-1 SOSIP Envelopes that Show Similarities with Envelopes on Native Virions.
    Stadtmueller BM; Bridges MD; Dam KM; Lerch MT; Huey-Tubman KE; Hubbell WL; Bjorkman PJ
    Immunity; 2018 Aug; 49(2):235-246.e4. PubMed ID: 30076100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques.
    Ortiz AM; Flynn JK; DiNapoli SR; Vujkovic-Cvijin I; Starke CE; Lai SH; Long ME; Sortino O; Vinton CL; Mudd JC; Johnston L; Busman-Sahay K; Belkaid Y; Estes JD; Brenchley JM
    Nat Med; 2018 Sep; 24(9):1313-1316. PubMed ID: 30061696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accidental Father-to-Son HIV-1 Transmission During the Seroconversion Period.
    Ezeonwumelu I; Bártolo I; Martin F; Abecasis A; Campos T; Romero-Severson EO; Leitner T; Taveira N
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):857-862. PubMed ID: 30073842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.